Launch of germline gene editing commission provides first look at priorities, representatives

An international commission tasked with creating a framework for assessing potential clinical applications of human germline genome editing launched Wednesday, providing the first details of the composition of its membership and oversight board, timeline and scope. The commission, convened by the U.S. National Academy of Medicine, the U.S. National Academy

Read the full 504 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE